Back to search results

Encorafenib Plus Cetuximab in a Neoadjuvant Setting in Patients With BRAF Mutation Localised Colon or Upper Rectum Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Colorectal Cancer · BRAF V600E Mutation Positive

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Chu - Hôpital Européen Georges Pompidou, Paris, France

    Contact: Study coordinator (Claire GALLOIS, Dr) · claire.gallois@aphp.fr · 0156092297
    Contact: Principal Investigator (Claire GALLOIS, Dr)
Study leads

  • Claire Gallois, MD

    Principal Investigator

    Paris HEGP

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)